These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 682039)

  • 1. Metabolism of 125I-hGH in uremia and the effect of dialytic treatment.
    Maneschi F; Navalesi R; Pilo A; Paci A; Rindi P
    J Nucl Med Allied Sci; 1978; 22(1):31-5. PubMed ID: 682039
    [No Abstract]   [Full Text] [Related]  

  • 2. [GH, insulin and glucide intolerance in chronic uremia. Changes during hemodialysis treatment and after renal transplantation].
    Orsoni G; Capelli M; Scolari MP; Vangelista A; Bonomini V
    Minerva Nefrol; 1980; 27(4):655-8. PubMed ID: 7019773
    [No Abstract]   [Full Text] [Related]  

  • 3. The analysis of concentration dependence of uremic lesions in clinical studies.
    Sargent JA; Gotch FA
    Kidney Int Suppl; 1975 Jan; (2):35-44. PubMed ID: 1057691
    [No Abstract]   [Full Text] [Related]  

  • 4. Growth hormone metabolism in uremia.
    Santos F; Orejas G; Rey C; García-Vicente S; Málaga S
    Child Nephrol Urol; 1991; 11(3):130-3. PubMed ID: 1777890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrinology and metabolism in uremia and dialysis: a clinical review.
    Feldman HA; Singer I
    Medicine (Baltimore); 1975 Sep; 54(5):345-76. PubMed ID: 808679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Calcium, magnesium and sodium in the tissues of patients on long-term treatment with hemodialysis].
    Janicka L; Ksiazek A; Schabowski J; Krasucki W
    Pol Tyg Lek; 1980 Mar; 35(11):383-5. PubMed ID: 7383925
    [No Abstract]   [Full Text] [Related]  

  • 7. Albumin catabolism measurement by a double tracer technique in uraemic patients during a single dialytic treatment.
    Mariani G; Bianchi R; Pilo A; Palla R; Toni MG; Fusani L
    Eur J Clin Invest; 1974 Dec; 4(6):435-42. PubMed ID: 4140782
    [No Abstract]   [Full Text] [Related]  

  • 8. The roles of renal catabolism and uremia in modifying the clearance of fibrinogen and its degradative fragments D and E.
    Iio A; Rutherford WE; Wochner RD; Spilberg I; Sherman LA
    J Lab Clin Med; 1976 Jun; 87(6):934-46. PubMed ID: 932524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin catabolism in chronic uraemia and in anephric man before and after dialysis treatment.
    Navalesi R; Pilo A; Maggiore Q; Lenzi S; Cecchetti P; Donato L
    Proc Eur Dial Transplant Assoc; 1972; 9():119-25. PubMed ID: 4668904
    [No Abstract]   [Full Text] [Related]  

  • 10. Derangement of acid-base balance in uremia and under hemodialysis.
    Messa P; Mioni G; Maio GD; Ferrando C; Lamperi D; Famularo A; Paoletti E; Cannella G
    J Nephrol; 2001; 14 Suppl 4():S12-21. PubMed ID: 11798141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin metabolism in chronic uremia and in the anephric state: effect of the dialytic treatment.
    Navalesi R; Pilo A; Lenzi S; Donato L
    J Clin Endocrinol Metab; 1975 Jan; 40(1):70-85. PubMed ID: 1089679
    [No Abstract]   [Full Text] [Related]  

  • 12. Disappearnace of human growth hormone 125 I in the anephric non-uraemic and uraemic rat.
    Rabkin R; Pimstone BL; Marks T; Eales L
    Horm Metab Res; 1972 Nov; 4(6):467-9. PubMed ID: 4655502
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemodialysis adequacy: basic essentials and practical points for the nephrologist in training.
    Depner TA
    Hemodial Int; 2005 Jul; 9(3):241-54. PubMed ID: 16191074
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of the cephalosporins in healthy volunteers and uremic patients.
    Kirby WM; De Maine JB; Serrill WS
    Postgrad Med J; 1971 Feb; 47():Suppl:41-6. PubMed ID: 5556189
    [No Abstract]   [Full Text] [Related]  

  • 15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of factors influencing the hemodynamic and metabolic response to periodic hemodialysis treatment].
    Lojacono L; Butti A; Castagneto M; Cagossi M; Salerni B; Pigliucci GM
    Chir Patol Sper; 1971 Apr; 19(2):120-35. PubMed ID: 5155718
    [No Abstract]   [Full Text] [Related]  

  • 17. [Criteria for the selection of dialytic treatment in uremia].
    Monasterio G
    Minerva Nefrol; 1969; 16(5):333-4. PubMed ID: 5399506
    [No Abstract]   [Full Text] [Related]  

  • 18. Benefits of early initiation of dialysis.
    Bonomini V; Feletti C; Scolari MP; Stefoni S
    Kidney Int Suppl; 1985 Dec; 17():S57-9. PubMed ID: 3937938
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors underlying abnormal zinc metabolism in uremia.
    Mahajan SK; Bowersox EM; Rye DL; Abu-Hamdan DK; Prasad AS; McDonald FD; Biersack KL
    Kidney Int Suppl; 1989 Nov; 27():S269-73. PubMed ID: 2636669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical selective criteria for the dialytic treatment of uremia].
    Giovannetti S
    Minerva Nefrol; 1969; 16(5):334-7. PubMed ID: 5399507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.